Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Haemonetics Corp (NYSE:HAE)

35.95
Delayed Data
As of Aug 28
 -0.17 / -0.47%
Today’s Change
33.75
Today|||52-Week Range
45.43
-3.93%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues227.6M231.8M226.5M213.4M
 
 
 
 
 
Cost of Goods Sold98.4M97.9M96.0M88.6M
 
 
 
 
 
Depreciation And Amortization21.1M22.3M22.2M22.3M
 
 
 
 
 
 
Operating ExpensesGross Income108.1M111.7M108.4M102.5M
 
 
 
 
 
General Expenses80.4M80.5M81.3M84.1M
 
 
 
 
 
Research And Development10.9M10.6M17.2M11.3M
 
 
 
 
 
Total Operating Expenses199.8M200.7M199.4M195.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income27.8M31.2M27.1M18.4M
 
 
 
 
 
Extraordinary Credit2.8M----637.0K
 
 
 
Extraordinary Charge-15.3M-12.9M-15.5M-14.8M
 
 
 
 
 
Interest Expense On Debt5.2M2.3M1.9M2.6M
 
 
 
 
 
Other Expenses-235.0K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income9.8M16.0M9.7M1.6M
 
 
 
 
 
Income Taxes-2.3M-36.0K-12.6M-1.9M
 
 
 
 
 
Net Income7.5M16.0M-2.9M-267.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS51.4M51.4M51.6M51.4M
 
 
 
 
 
Shares To Calculate EPS Diluted51.9M52.0M51.6M51.4M
 
 
 
 
 
 
Earnings Per ShareEPS$0.14$0.31-$0.06-$0.01
 
 
 
 
 
EPS Diluted$0.14$0.31-$0.06-$0.01